Guidance for Industry on How to Use E-Mail Submit Information in Electronic Format to CVM Using the FDA Electronic Submission Gateway

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form FDA 3538 Electronic Submission System Participant Management Form	Form and Instruction	Modified	Available
Guidance- 0910-0454.pdf	Supplementary Document	Uploaded 2010-05-17	Available
0454 SS A 2013.doc	Supporting Statement A	Uploaded 2013-09-12	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
6144	Guidance- How to Use E-Mail to Submit Information to CVM in Electronic Format Using The FDA Electronic Submission Gateway	Form and Instruction	Modified	Electronic Submission System Participant Management Form

ICR Details

OMB Control No: 0910-0454	ICR Reference No: 201309-0910-004
Status: Historical Active	Previous ICR Reference No: 201005-0910-013
Agency/Subagency: HHS/FDA	Agency Tracking No: 20469
Title: Guidance for Industry on How to Use E-Mail Submit Information in Electronic Format to CVM Using the FDA Electronic Submission Gateway
Type of Information Collection: Extension without change of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 11/21/2013
Retrieve Notice of Action (NOA)	Date Received in OIRA: 09/13/2013
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	11/30/2016	36 Months From Approved	11/30/2013
Responses	156	0	16
Time Burden (Hours)	12	0	1
Cost Burden (Dollars)	0	0	0

---

Abstract: This collection request covers certain electronic submissions with no requirements for a paper copy. These types of documents are listed in public docket 97S-0251 (subsequently changed to FDA-1992-S-0039) as required by 21 CFR 11.2. CVM's guidance entitled "Guidance for Industry: How to Submit Information in Electronic Format to CVM Using the FDA Electronic Submission Gateway," outlines how to register with CVM's Electronic Submission System (ESS). The likely respondents are sponsors of new animal drug applications who want to submit pre-market information to CVM using the FDA Electronic Submissions Gateway (ESG).

---

Authorizing Statute(s): US Code: 21 USC 360b
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	78 FR 28851	05/16/2013
30-day Notice:	Federal Register Citation:	Citation Date:
	78 FR 53772	08/30/2013
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 1

table that charts list of burden

IC Title	Form No.	Form Name
Guidance- How to Use E-Mail to Submit Information to CVM in Electronic Format Using The FDA Electronic Submission Gateway	FDA 3538	Electronic Submission System Participant Management Form

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	156	16	0	0	140	0
Annual Time Burden (Hours)	12	1	0	0	11	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Extension of a currently approved collection.

---

Annual Cost to Federal Government: $559

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 09/13/2013

---